|  Help  |  About  |  Contact Us

Publication : Distinct use of super-enhancer elements controls cell type-specific CD25 transcription and function.

First Author  Spolski R Year  2023
Journal  Sci Immunol Volume  8
Issue  89 Pages  eadi8217
PubMed ID  37922339 Mgi Jnum  J:364832
Mgi Id  MGI:8172543 Doi  10.1126/sciimmunol.adi8217
Citation  Spolski R, et al. (2023) Distinct use of super-enhancer elements controls cell type-specific CD25 transcription and function. Sci Immunol 8(89):eadi8217
abstractText  The IL-2 receptor alpha chain (IL-2Ralpha/CD25) is constitutively expressed on double-negative (DN2/DN3 thymocytes and regulatory T cells (T(regs)) but induced by IL-2 on T and natural killer (NK) cells, with Il2ra expression regulated by a STAT5-dependent super-enhancer. We investigated CD25 regulation and function using a series of mice with deletions spanning STAT5-binding elements. Deleting the upstream super-enhancer region mainly affected constitutive CD25 expression on DN2/DN3 thymocytes and T(regs), with these mice developing autoimmune alopecia, whereas deleting an intronic region decreased IL-2-induced CD25 on peripheral T and NK cells. Thus, distinct super-enhancer elements preferentially control constitutive versus inducible expression in a cell type-specific manner. The mediator-1 coactivator colocalized with specific STAT5-binding sites. Moreover, both upstream and intronic regions had extensive chromatin interactions, and deletion of either region altered the super-enhancer structure in mature T cells. These results demonstrate differential functions for distinct super-enhancer elements, thereby indicating previously unknown ways to manipulate CD25 expression in a cell type-specific fashion.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

37 Bio Entities

Trail: Publication

0 Expression